Literature DB >> 7004812

Effect of guar gum on 24-hour insulin requirements of insulin-dependent diabetic subjects as assessed by an artificial pancreas.

J S Christiansen, V Bonnevie-Nielsen, P A Svendsen, P Rubin, B Rønn, J Nerup.   

Abstract

The effect of guar gum on insulin requirements, mean blood glucose (MBG), and mean amplitude of glycemic excursions (MAGE) was investigated in seven insulin-dependent diabetic subjects without endogenous insulin secretion by means of an artificial pancreas (Biostator). Fifty-four hours after the withdrawal of long-acting insulin, the patients were controlled for two consecutive days by the artificial pancreas, under standardized identical conditions, except for the ingestion of guar gum before meals on the second day. The 24-h insulin requirements were significantly reduced by 12.4% on the day with guar gum (P < 0.05). No statistically significant effects were observed on MGG and MAGE.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004812     DOI: 10.2337/diacare.3.6.659

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Comparison of glycemic response and insulin requirements after mixed meals of equal carbohydrate content in healthy, type-1, and type-2 diabetic man.

Authors:  J Schrezenmeir; F Tatò; S Tatò; E Küstner; U Krause; G Hommel; N G Asp; H Kasper; J Beyer
Journal:  Klin Wochenschr       Date:  1989-10-02

2.  The diabetic diet, dietary carbohydrate and differences in digestibility.

Authors:  D J Jenkins; R H Taylor; T M Wolever
Journal:  Diabetologia       Date:  1982-12       Impact factor: 10.122

3.  Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas.

Authors:  H Gin; G Slama; P Weissbrodt; T Poynard; P Vexiau; J C Klein; G Tchobroutsky
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

4.  Postprandial hyperglycemia after ingestion of peeled and non-peeled fruits in type-2 diabetics.

Authors:  N Katsilambros; P Philippides; J Boletis; K Mavroudis; D Frangaki; M Marangos; G K Daikos
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.